diindolylmethane (DIM)
Bell MC, Crowley-Norwick P, Bradlow HL, Sepkovic DW, Schmidt-Grimminger D, Howell P, Mayeaux EJ, Tucker A, Turbat-Herrera EA, Mathis JM.
Placebo-controlled trial of indole-3-carbinol in the treatment of CIN.
http://www.ncbi.nlm.nih.gov/Abstract
Bradlow HL, Sepkovic DW, Telang NT, Osborne MP.
Indole-3-carbinol. A novel approach to breast cancer prevention.
http://www.ncbi.nlm.nih.gov/Abstract
Chen I, McDougal A, Wang F, Safe S.
Aryl hydrocarbon receptor-mediated antiestrogenic and antitumorigenic activity of diindolylmethane (DIM).
http://www.ncbi.nlm.nih.gov/Abstract
Garikapaty VP, Ashok BT, Tadi K, Mittelman A, Tiwari RK.
Synthetic dimer of indole-3-carbinol: second generation diet derived anti-cancer agent in hormone sensitive prostate cancer. Prostate. 2006 Apr 1;66(5):453-62.
http://www.ncbi.nlm.nih.gov/Abstract
Sarkar FH, Li Y.
Indole-3-carbinol and prostate cancer. J Nutr. 2004 Dec;134(12 Suppl):3493S-3498S.
http://www.ncbi.nlm.nih.gov/Abstract
Sasieni P.
Chemoprevention of cervical cancer. Best Pract Res Clin Obstet Gynaecol. 2006 Apr;20(2):295-305. Epub 2006 Jan 4.
http://www.ncbi.nlm.nih.gov/Abstract
Wattenberg LW.
Inhibition of neoplasia by minor dietary constituents.
http://www.ncbi.nlm.nih.gov/Abstract
Wattenberg LW, Loub WD.
Inhibition of polycyclic aromatic hydrocarbon-induced neoplasia by naturally occurring indoles.
- INTERPHARMA PRAHA, a.s., Komoranska 955, 143 10 Praha 12, Czech Republic
- Business Development: 00420-241 773 242
- Secretariat: 00420-241 773 242, Fax: 00420-241 773 235
- Email: